Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pancreatic Neoplasms × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 2 Pain 2 Visceral Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neoplasms 1 Liver Neoplasms 1 Leiomyoma 1 Head and Neck Neoplasms 1 Bone Neoplasms 1 Agnosia 1

Interventions

Ethanol 3 fish oil triglycerides 2 S 1 (combination) 2 Metronidazole 2 Long-Term Synaptic Depression 2 Gemcitabine 2 Dexamethasone 2 pembrolizumab 1 pasireotide 1 nimotuzumab 1 ferumoxtran-10 1 alanylglutamine 1 Tobacco Use Cessation Devices 1 TachoSil 1 Sunitinib 1 Stents 1 Psychiatric Rehabilitation 1 Pregabalin 1 Polymerase Chain Reaction 1 Polygeline 1 Parenteral Nutrition 1 Pancrelipase 1 Pancreaticojejunostomy 1 Oxaliplatin 1 Nutritional Status 1 Needles 1 Mirtazapine 1 Immunonutrition Diet 1 Hydrocortisone 1 Glucocorticoids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01768988 2017-10-06

PANPAIN/1

Parc de Salut Mar

Phase 4 Terminated

Gastrointestinal

Pancreatic Neoplasms, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡